A research study within the US Military Health System deploys Clinical ink’s platform among those with and without COVID-19 to understand long COVID Horsham, PA […]
Cleaner Data, Real-Time Review Advances in the treatment of systemic lupus erythematosus (SLE), the most common type of lupus, have been few and far between.
Transforming Lupus Trials with Direct Data Capture Read More...
WILMINGTON, N.C. (March 22, 2021) – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, and Clinical ink, a global clinical technology company, have
Horsham, Pa.; June 2, 2020 – Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment for cytokine storm,
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
